Next Article in Journal
Effect of COVID-19 on Anti-S Antibody Response in Healthcare Workers Six Months Post-Vaccination
Next Article in Special Issue
Immunogenicity and Safety of an Intradermal BNT162b2 mRNA Vaccine Booster after Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population
Previous Article in Journal
Transdermal Vaccination with the Matrix-2 Protein Virus-like Particle (M2e VLP) Induces Immunity in Mice against Influenza A Virus
Previous Article in Special Issue
Antibody Responses to SARS-CoV-2 Infection—Comparative Determination of Seroprevalence in Two High-Throughput Assays versus a Sensitive Spike Protein ELISA
 
 
Article

Article Versions Notes

Vaccines 2021, 9(11), 1326; https://doi.org/10.3390/vaccines9111326
Action Date Notes Link
article xml file uploaded 15 November 2021 12:00 CET Original file -
article xml uploaded. 15 November 2021 12:00 CET Update https://www.mdpi.com/2076-393X/9/11/1326/xml
article pdf uploaded. 15 November 2021 12:00 CET Version of Record https://www.mdpi.com/2076-393X/9/11/1326/pdf
article html file updated 15 November 2021 12:01 CET Original file -
article html file updated 30 July 2022 16:42 CEST Update https://www.mdpi.com/2076-393X/9/11/1326/html
Back to TopTop